Volume Spike Investor » CYTR http://vsinvestor.com Investing in stocks based on short term spikes in volume Sat, 05 Nov 2011 14:20:15 +0000 en hourly 1 http://wordpress.org/?v=3.2 Volume Alert: CytRx Corp. (CYTR) http://vsinvestor.com/2009/06/volume-alert-cytrx-corp-cytr.html http://vsinvestor.com/2009/06/volume-alert-cytrx-corp-cytr.html#comments Tue, 30 Jun 2009 15:20:12 +0000 247admin http://www.vsinvestor.com/?p=636 CytRx Corp. (Nasdaq: CYTR) shares are up 8%, near $1 a share, and have traded a day’s average daily volume in the first two hours of trading after the company filed a report with the FDA offering data to support continuation of one of its key Phase II clinical trials.

“We are confident that the information included in this report, including results from a detailed animal toxicology study, sufficiently addresses the agency’s concerns,” said Steven A. Kriegsman, CytRX CEO, in a statement.

The company expects the FDA to review its report supporting continuation of the Phase II trial for dr candidate arimoclomol in Lou Gherig’s disease. The FDA had placed a partial hold on the trial in January 2009 — Mike Tarsala

]]> http://vsinvestor.com/2009/06/volume-alert-cytrx-corp-cytr.html/feed 0